Tags

Type your tag names separated by a space and hit enter

Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Department of Psychiatry Université de Montréal, Montréal, Québec, Canada Centre de recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal, Montréal, Québec, Canada stephane.potvin@umontreal.ca Department of Psychiatry, Université de Montréal, Montréal, Québec, Canada Centre de Recherche de l'Institut Universitaire de gériatrie de Montréal, Montréal, Québec, Canada Center for Research in Aging, Donald Berman Maimonides Geriatric Center, Montreal, Québec, Canada Department of Psychiatry, Université de Montréal, Montréal, Québec, Canada Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal, Montréal, Québec, Canada.

    ,

    Source

    MeSH

    Adult
    Amygdala
    Antipsychotic Agents
    Appetite
    Arachidonic Acids
    Benzodiazepines
    Biomarkers
    Endocannabinoids
    Female
    Humans
    Magnetic Resonance Imaging
    Male
    Olanzapine
    Polyunsaturated Alkamides
    Schizophrenia
    Treatment Outcome
    Weight Gain
    Young Adult

    Pub Type(s)

    Letter

    Language

    eng

    PubMed ID

    25370126

    Citation

    Potvin, Stéphane, et al. "Anandamide Is Involved in Appetite-related Amygdala Hyperactivations in Schizophrenia Patients Treated With Olanzapine: a Functional Magnetic Resonance Imaging Study." Journal of Clinical Psychopharmacology, vol. 35, no. 1, 2015, pp. 82-3.
    Potvin S, Lungu OV, Stip E. Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study. J Clin Psychopharmacol. 2015;35(1):82-3.
    Potvin, S., Lungu, O. V., & Stip, E. (2015). Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study. Journal of Clinical Psychopharmacology, 35(1), pp. 82-3. doi:10.1097/JCP.0000000000000236.
    Potvin S, Lungu OV, Stip E. Anandamide Is Involved in Appetite-related Amygdala Hyperactivations in Schizophrenia Patients Treated With Olanzapine: a Functional Magnetic Resonance Imaging Study. J Clin Psychopharmacol. 2015;35(1):82-3. PubMed PMID: 25370126.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study. AU - Potvin,Stéphane, AU - Lungu,Ovidiu V, AU - Stip,Emmanuel, PY - 2014/11/6/entrez PY - 2014/11/6/pubmed PY - 2015/9/1/medline SP - 82 EP - 3 JF - Journal of clinical psychopharmacology JO - J Clin Psychopharmacol VL - 35 IS - 1 SN - 1533-712X UR - https://www.unboundmedicine.com/medline/citation/25370126/Anandamide_is_involved_in_appetite_related_amygdala_hyperactivations_in_schizophrenia_patients_treated_with_olanzapine:_a_functional_magnetic_resonance_imaging_study_ L2 - http://Insights.ovid.com/pubmed?pmid=25370126 DB - PRIME DP - Unbound Medicine ER -